Help patients express priorities clearly
- Trial ID
- NCT04179695
- Official Title
- Optimizing PD Patient's Health Pathways: Favoring Global, Patient Centered Care by a New Communication Aid Tool PARKINSUN
- Goal
- Help patients express priorities clearly
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Lille
- Study Type
- INTERVENTIONAL
- Enrollment
- 120 participants
- Conditions
- Parkinson's Disease
- Interventions
- Consulting with PARKINSUN as communication aid-tool, Consulting without PARKINSUN as communication aid-tool
Summary For Families
The goal is to make Parkinson's care more global and patient centered by improving how patients and clinicians talk about symptoms, priorities, and care plans during visits. The approach uses a communication aid called PARKINSUN during consultations, it prompts and structures patients' symptoms, concerns, and goals, creates a clear summary to help clinicians prioritize issues and guide shared decision making, and is compared to usual consultations without the tool. Adults 18 to 90 with Parkinson's at any stage who can consent and attend visits, have no severe other neurological or psychiatric disease, score above 22 on the MOCA, speak French, and have social security coverage are eligible; people under guardianship or unable to complete the study are excluded.
Locations
- Hopital Roger Salengro, CHU Lille, Lille, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Consulting with PARKINSUN as communication aid-tool. The goal is to make Parkinson's care more global and patient centered by improving how patients and clinicians talk about symptoms, priorities, and care plans during visits. The approach uses a communication aid called PARKINSUN during consultations, it prompts and structures patients' symptoms, concerns, and goals, creates a clear summary to help clinicians prioritize issues and guide shared decision making, and is compared to usual consultations without the tool. Adults 18 to 90 with Parkinson's at any stage who can consent and attend visits, have no severe other neurological or psychiatric disease, score above 22 on the MOCA, speak French, and have social security coverage are eligible; people under guardianship or unable to complete the study are excluded.
- Who can participate?
- Participants must be between 18 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 years and 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.